Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs

We investigated whether rimonabant, a type 1 cannabinoid receptor antagonist, reduces visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) in dogs maintained on a hypercaloric high-fat diet (HHFD). To determine whether energy expenditure contributed to body weight changes, we also cal...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Richey, Joyce M., Woolcott, Orison O., Stefanovski, Darko, Harrison, L. Nicole, Zheng, Dan, Lottati, Maya, Hsu, Isabel R., Kim, Stella P., Kabir, Morvarid, Catalano, Karyn J., Chiu, Jenny D., Ionut, Viorica, Kolka, Cathryn, Mooradian, Vahe, Bergman, Richard N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Physiological Society 2009
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3833919/
https://ncbi.nlm.nih.gov/pubmed/19366874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.90972.2008
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller